More about
Her2-Positive Breast Cancers
News
April 04, 2022
1 min watch
Save
VIDEO: ‘Practice changing’ data on early-stage triple-negative breast cancer immunotherapy
In this video, Sara Hurvitz, MD, discussed the "practice changing" data from the KEYNOTE-522 phase 3 trial reviewed at 39th Miami Breast Cancer Conference.